Changes in energy status ignite neural circuits that maintain body weight by engaging peripheral mechanisms that control energy expenditure; obesity results for when these responses are no longer sufficient. The key neural circuits that stimulate energy expenditure have not yet been established, but previous research has identified several critical sites (e.g. preoptic area (POA) and ventromedial hypothalamus (VMN)) that could be part of an interconnected system that controls tissue thermogenesis, which is essential for body weight control. Activating SF1-cre VMN cells in male diet-induced obese mice reduces body fat by 25% in 72 hours. This function is likely mediated at least in part by release of the peptide pituitary adenylate cyclase-activating polypeptide (PACAP), since knockout of PACAP in the VMN induces obesity at thermoneutrality (30C) and suppresses temperature above both the brown and beige adipose tissue in response to feeding. Because some VMN cells densely project to the POA, we hypothesized that VMN PACAP cells activate tissue thermogenesis via preoptic outputs. We placed temperature-sensing microchips above a traditional brown (interscapular brown adipose tissue (iBAT) and beige (inguinal white adipose tissue (iWAT) adipose tissue in Adcyap1(gene for PACAP)cre mice with DIO-ChR2 in the VMN and fiber optic implants in two major VMN outputs: the POA and the bed nucleus of the stria terminalis (BST). Activating VMN fibers in the POA that contain PACAP in both male and female mice, but not the BST, increased iBAT and iWAT temperature, and the effect was most robust when the mice were fasted. In summary, these data indicate that VMN PACAP connections with the POA is important for the induction of tissue thermogenesis, particularly when feeding conditions change. VMN PACAP, as well as associated signaling targets, are critical components to energy balance by activating adipose tissue mechanisms that stimulate energy expenditure. Disclosure A.J.Elmendorf: Other Relationship; Eli Lilly and Company. C.A.Mahler: Stock/Shareholder; AbbVie Inc., Pfizer Inc., AstraZeneca. B.Lorentz: Research Support; Eli Lilly and Company. J.Flak: Research Support; Eli Lilly and Company. Funding American Diabetes Association (Pathway 17-INI-15 to J.F.); Ralph W. and Grace M. Showalter Research Trust; Indiana University; Indiana Biosciences Research Institute
Read full abstract